Possibilities of combined correction of blood circulation and fat metabolism in hypertension and obesity

Abstract

We examined 142 male patients, aged from 36 to 50 years, with a diastolic blood pressure level in the range of 90-104 mmHg. All patients received basic therapy with enalapril 10 mg per day. Patients with obesity and hypertension and patients suffering only from hypertension, in addition to basic therapy, received trecrezan at a dose of 600 mg/day for 21 days, 2 courses for 6 months. Trecrezan improved lipid metabolism and cardiac hemodynamic parameters.